Meturedepa

TargetMol
Product Code: TAR-T28031
Supplier: TargetMol
CodeSizePrice
TAR-T28031-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28031-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28031-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Meturedepa is an antineoplastic agent.
CAS:
1661-29-6
Formula:
C11H22N3O3P
Molecular Weight:
275.289
Purity:
0.98
SMILES:
CCOC(=O)NP(=O)(N1CC1(C)C)N1CC1(C)C

References

1. Moore GE, Bross ID, Ausman R, Nadler S, Jones R Jr, Slack N, Rimm AA. Effects of meturedepa (NSC-51325) in 233 patients with advanced cancer. Eastern Clinical Drug Evaluation Program. Cancer Chemother Rep. 1968 Oct;52(6):667-73. PubMed PMID: 4895430. 2. Ambrus JL, Ambrus CM, Bardos TJ, Chmielewicz ZF. Radiation sensitizing agents in clinical radiation and chemotherapy. J Med. 1980;11(1):29-38. PubMed PMID: 6156977. 3. WATNE AL, MOORE GE, ROSS CA, AMBRUS JL. Clinical experience with AB-132. Cancer Chemother Rep. 1962 Feb;16:421-3. PubMed PMID: 14005262. 4. BACK N, BARDOS TJ, CHMIELEWICZ ZF, ACHTER E, MUNSON AE. STUDIES ON THE MECHANISM OF ACTION OF CYCLOPHOSPHAMIDE AND AB-132 WITH THE AID OF RADIOPROTECTIVE AGENTS. Life Sci (1962). 1964 Aug;3:803-8. PubMed PMID: 14201688.